Why Dark Circles Get Worse After Menopause: What the Skin Perfusion Research Shows

In this article - Why does the skin under your eyes get darker after menopause? - What is actually under that thin skin? - What does the collagen research on shilajit actually show? - Why don't the usual fixes work? - How is Optimum Shilajit different from a topical cream? - Common questions about dark circles after menopause

Why does the skin under your eyes get darker after menopause?

The skin under your eyes is the thinnest skin on your body, even before menopause. Two things held it up for most of your life. A steady layer of collagen, and estrogen signaling that kept the smallest blood vessels underneath it open and working normally.

Estrogen does not just manage hot flashes and periods. It also tells skin cells to keep producing type I collagen, the structural protein that gives skin its thickness and resilience. When estrogen drops at menopause, collagen production slows across the whole body. It slows fastest in the skin that was already thinnest to begin with.

Thinner skin does not create new pigment. It just stops hiding what was always there. The small veins under your eyes carry blood that has already released its oxygen. That blood runs darker, bluer, and more purple than freshly oxygenated blood. Through skin thick enough to obscure it, that color never reaches the surface. Through skin that has lost its collagen cushion, it does.

The timeline women actually describe

Many women describe dark circles arriving abruptly rather than gradually. "Fine" one year, then a clear change within a year or two of the final period. That timing fits how quickly collagen synthesis falls once estrogen withdraws, rather than the slow, decades-long fade that aging alone would produce.

What is actually under that thin skin?

A 2023 review by Poh and colleagues, published in Clinics in Plastic Surgery, laid out the four recognized subtypes of periorbital hyperpigmentation. Pigmented (true melanin excess), vascular (visible blood vessels through thin skin), structural (shadows from bone and fat changes), and mixed. The review's point, echoed across the dermatology literature, is that "classification of POH is divided into pigmented, vascular, structural, and mixed subtypes," and treatment only works when it is matched to the correct type.

This matters because the skincare aisle is built almost entirely for the pigmented type.

Five things look like pigment but aren't:

• A grey-blue cast. Deoxygenated blood reads blue-grey through thin skin, which the eye reads as a shadow or a stain.
• A deeper tone by afternoon. As skin dehydrates slightly over the day, it can thin further, making the vascular pattern more visible by evening.
• A tone that resists every brightening product. If six months of vitamin C and retinol changed nothing, that is data, not a failure of effort.
• A shadow that photographs darker than it looks in the mirror. Camera flash exaggerates the blue-red tone of visible blood vessels more than it exaggerates true pigment.
• A circle that looks worse when you're tired. Fatigue and dehydration both thin skin slightly and slow circulation, making an existing vascular pattern read darker without adding any new pigment.

What does the collagen research on shilajit actually show?

In 2019, Das and colleagues ran a randomized, placebo-controlled trial in 45 healthy middle-aged women, mean age just over 42. Three groups, 14 weeks. Placebo, 125 mg shilajit twice daily, and 250 mg shilajit twice daily. The trial is notable for what it actually did. Researchers took skin biopsies at week two and week fourteen and ran genetic analysis on the tissue itself, rather than relying on a visual score.

At the higher dose, three collagen genes switched on, COL1A1, COL5A2, and COL14A1, each significantly elevated compared to placebo by week fourteen. The same dose also improved measured skin perfusion, meaning blood flow through the tissue. Researchers noted increased reddish coloration on dermoscopic analysis that reflected healthier circulation, not pigment. The lower dose activated the same collagen genes without moving the perfusion measurement, so the dose mattered.

The researchers' own conclusion was specific. "Oral shilajit supplementation in adult healthy women induced genes relevant to endothelial cell migration and growth of blood vessels." That finding became the basis of US Patent 11,077,045 B2, with Ohio State University's Dr. Chandan K. Sen among the listed co-inventors.

What this trial did not show, stated plainly

This was not a dark-circles trial. A few things to be clear about:

• No under-eye photographs were scored.
• No dark-circle severity index was used.
• The women studied were not described as postmenopausal, just healthy and middle-aged.
• The trial found no difference between shilajit and placebo on skin elasticity, hydration, or water loss. That is a safety finding, not an efficacy win.

What it shows is mechanism. The biological machinery that builds collagen and feeds skin with blood can be activated by oral shilajit at a measured dose. Whether that translates into less visible vascular dark circles in a postmenopausal population is a question this trial was not designed to answer, and no honest reading of the data should claim otherwise.

Why don't the usual fixes work?

Each of the common remedies for dark circles was built to solve a different problem than the one menopause creates.

• Caffeine eye cream temporarily constricts blood vessels, which can reduce the visible color for an hour or two, but it does nothing to the collagen layer and wears off by midday.
• Retinol works on the outer layers of skin and can thicken the epidermis over months, but it was not designed to rebuild the deeper collagen network or change blood flow.
• Dermal filler is built for a hollow, a loss of volume. If your skin is thin but not hollow, filler can add bulk without addressing the transparency, and in thin skin it can occasionally add a grey-blue cast of its own.
• Concealer sits on top of a color coming from underneath, and on skin this thin, it can settle into fine lines and become more visible by afternoon rather than less.

None of these four approaches touch collagen synthesis. That is the layer menopause actually changed.

How is Optimum Shilajit different from a topical cream?

Optimum Shilajit is a purified resin from the Altai mountains, standardized to 78% fulvic and humic acids. Taken as two tablets with breakfast, rather than applied to the skin. The mechanism is internal rather than topical. Fulvic acid supports the body's own estrogen signaling pathways, the same signaling that tells skin cells to keep producing collagen in the first place.

That is a meaningfully different approach than a cream sitting on the surface of skin that has already thinned. It is also why the research above measured biopsied tissue and blood flow rather than a surface reading, because the question was whether the underlying structure could be addressed, not whether a product could temporarily mask what is showing through it.

Optimum Shilajit

Not every shilajit sold online is standardized the same way. Most commercial shilajit powder tests at 15 to 20% fulvic and humic acids, often with no published lab certificate at all. Optimum Shilajit is third-party tested for heavy metals and purity, with results published rather than claimed, made in small batches by a family-owned company based in Florida, with a 90-day money-back guarantee.

See Optimum Shilajit